Methylprednisolone/pembrolizumabLack of efficacy, immune checkpoint inhibitors-induced interstitial lung disease and fulminant myocarditis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2023卷 / 1期
关键词：
D O I：
10.1007/s40278-024-65840-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 241
相关论文
共 50 条
  • [1] Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series
    Coustal, Cyrille
    Vanoverschelde, Juliette
    Quantin, Xavier
    Lesage, Candice
    Michot, Jean-Marie
    Lappara, Ariane
    Ederhy, Stephane
    Assenat, Eric
    Faure, Maxime
    Issa, Nahema
    Lambotte, Olivier
    Puyade, Mathieu
    Dereure, Olivier
    Tosi, Diego
    Rullier, Patricia
    Serre, Isabelle
    Larcher, Romaric
    Klouche, Kada
    Chanques, Gerald
    Vernhet-Kovacsik, Helene
    Faillie, Jean-Luc
    Agullo, Audrey
    Roubille, Francois
    Guilpain, Philippe
    Maria, Alexandre Thibault Jacques
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)
  • [2] Clinical course and prognosis of immune checkpoint inhibitors-induced myocarditis: A case series
    Coustal, C.
    Palassin, P.
    Quantin, X.
    Lesage, C.
    Roubille, F.
    Guilpain, P.
    Faillie, J. L.
    Maria, A.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 151 - 151
  • [3] Immune checkpoint inhibitors-induced eosinophilic pneumonia: A case report
    Hara, Kanako
    Yamasaki, Kei
    Tahara, Masahiro
    Kimuro, Rieko
    Yamaguchi, Yudai
    Suzuki, Yu
    Kawabata, Hiroki
    Kawanami, Toshinori
    Fujimoto, Naohiro
    Yatera, Kazuhiro
    [J]. THORACIC CANCER, 2021, 12 (05) : 720 - 724
  • [4] Cytomegalovirus pneumonia complicating immune checkpoint inhibitors-induced pneumonitis: A case report
    Badran, Omar
    Ouryvaev, Anton
    Baturov, Veronika
    Shai, Ayelet
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (06)
  • [5] Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors
    Arangalage, Dimitri
    Delyon, Julie
    Lermuzeaux, Mathilde
    Ekpe, Kenneth
    Ederhy, Stephane
    Pages, Cecile
    Lebbe, Celeste
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (09) : 683 - 684
  • [6] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Feifei Wang
    Yang Liu
    Wei Xu
    Changjing Zhang
    Jianhong Lv
    Shaolin Ma
    [J]. Journal of Medical Case Reports, 15
  • [7] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Wang, Feifei
    Liu, Yang
    Xu, Wei
    Zhang, Changjing
    Lv, Jianhong
    Ma, Shaolin
    [J]. JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [8] An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report
    Hashimoto, Takahiko
    Takahashi, Kosuke
    Ito, Kosuke
    Iwade, Kahori
    Torii, Atsushi
    Sugihara, Minoru
    Kondo, Haruka
    Hara, Toru
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03) : 218 - 222
  • [9] Methylprednisolone/mycophenolate-mofetil/pembrolizumabFulminant immune-checkpoint inhibitor (ICI)- induced myocarditis and lack of efficacy : case report
    [J]. Reactions Weekly, 2022, 1903 (1) : 235 - 235
  • [10] Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings
    Imai, Ryosuke
    Ono, Masafumi
    Nishimura, Naoki
    Suzuki, Koyu
    Komiyama, Nobuyuki
    Tamura, Tomohide
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (02) : E36 - E38
12345